It is suggested that epimedin C improves the secretion function of pancreatic β-cells, attenuates insulin resistance, increases serum insulin contents, promotes hepatic glycogen synthesis, and keeps FBG nearly constant in T2DM mice. The gene discussed is INS; the disease is Insulin resistance.